Cardiopulmonary effects of antimalarial drugs. 1. 4-Aminoquinolines: chloroquine quinetholate.
D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001249:Asthma / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002725:Chloroform; D002738:Chloroquine / Q000627:therapeutic use*; D004298:Dopamine / Q000032:analysis; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000032:analysis / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D008168:Lung / Q000032:analysis / Q000187:drug effects; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000032:analysis; D010047:Ovalbumin; D011804:Quinolines / Q000627:therapeutic use*; D011817:Rabbits; D012701:Serotonin / Q000032:analysis; D014655:Vascular Resistance / Q000187:drug effects
D006634:Histamine H1 Antagonists; D011804:Quinolines; D012701:Serotonin; D002725:Chloroform; D006632:Histamine; D002738:Chloroquine; D010047:Ovalbumin; D004298:Dopamine; D009638:Norepinephrine